HomeNDC LookupRxCUI directory › RxCUI 284205

Almotriptan 12.5 MG Oral Tablet — RxCUI 284205

RxNorm drug concept · Semantic clinical drug
RxCUI 284205 Semantic clinical drug · SCD ● Current RxNorm concept 6 FDA products 6 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI284205
Official nameAlmotriptan 12.5 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asalmotriptan malate 12.5 MG Oral Tablet
FDA products mapped6
Package NDCs mapped6
Reported Medicaid activity (SDUD)2,385 prescriptions · 22 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Almotriptan: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • No, almotriptan is not a regular painkiller like ibuprofen or acetaminophen. It's a specific migraine medicine called a triptan. It works by targeting the serotonin receptors invol...
  • What exactly is almotriptan for — is it the same as a regular painkiller?
  • It's best to take almotriptan as soon as you recognize a migraine is starting — you don't need to wait for the pain to peak. Taking it early generally gives the best results. If th...
  • When should I take it — do I wait until the headache is really bad?
📖 Read our full Almotriptan guide →

🕸️ Concept Web — How Almotriptan 12.5 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Almotriptan 12.5 MG Oral Tablet RxCUI 284205

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Almotriptan 279645
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Almotriptan Oral Tablet 374657
    • Almotriptan Oral Product 1164908
    • Almotriptan Pill 1164909
    • Oral Tablet 317541
    • Oral Product 1151131
    • Pill 1151133
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Almotriptan 12.5 MG 332453

Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Almotriptan 12.5 MG SCDC · 332453
  • Almotriptan Oral Tablet SCDF · 374657
  • Almotriptan Oral Product SCDG · 1164908
  • Almotriptan Pill SCDG · 1164909

📦 FDA Products & Package NDCs

6 products · 6 package NDCs
6 package NDCs map to RxCUI 284205 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00093-5260-18 6 BLISTER PACK in 1 CARTON (0093-5260-18) / 1 TABLET, FILM... Almotriptan Malate Teva Pharmaceuticals USA, Inc. 2015-07-07
00093-5261-29 12 BLISTER PACK in 1 CARTON (0093-5261-29) / 1 TABLET, FILM... Almotriptan Malate Teva Pharmaceuticals USA, Inc. 2015-07-07
00378-5245-85 1 BLISTER PACK in 1 CARTON (0378-5245-85) / 6 TABLET, FILM... Almotriptan Malate Mylan Pharmaceuticals Inc. 2015-11-10
00378-5246-85 2 BLISTER PACK in 1 CARTON (0378-5246-85) / 6 TABLET, FILM... Almotriptan Malate Mylan Pharmaceuticals Inc. 2015-11-10
27241-0041-11 1 BLISTER PACK in 1 CARTON (27241-041-11) / 6 TABLET, FILM... almotriptan Ajanta Pharma USA Inc. 2015-10-07
27241-0042-21 2 BLISTER PACK in 1 CARTON (27241-042-21) / 6 TABLET, FILM... almotriptan Ajanta Pharma USA Inc. 2015-10-07
Observed labelers: Ajanta Pharma USA Inc. (2) · Mylan Pharmaceuticals Inc. (2) · Teva Pharmaceuticals USA, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.